This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
n12	http://dx.doi.org/10.1002/
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q82913717

rdf:type

wikibase:Item

schema:description

2012年学术文章 2012年学术文章 vitenskapelig artikkel научни чланак artikull shkencor article científic наукова стаття, опублікована в січні 2012 articolo scientifico 2012年学术文章 scientific article published on 27 January 2012 επιστημονικό άρθρο wissenschaftlicher Artikel artykuł naukowy ২৭ জানুয়ারি ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年學術文章 vědecký článek научная статья мақолаи илмӣ artikel ilmiah vetenskaplig artikel artigo científico naučni članak 2012 nî lūn-bûn vedecký článok 2012年学术文章 article scientific scientific article published on 27 January 2012 บทความทางวิทยาศาสตร์ artikulong pang-agham 2012년 논문 tudományos cikk 2012年學術文章 articol științific 2012年学术文章 teaduslik artikkel tieteellinen artikkeli სამეცნიერო სტატია مقالة علمية نشرت في 27 يناير 2012 2012年學術文章 artigo científico artículu científicu 2012年の論文 2012年学术文章 bilimsel makale научни чланак מאמר מדעי vitskapeleg artikkel scientific article published on 27 January 2012 artículo científico publicado en 2012 article scientifique 2012年學術文章 bài báo khoa học 2012年學術文章 scienca artikolo научна статия wetenschappelijk artikel videnskabelig artikel udgivet 27. januar 2012 artigo científico

p:P577

wds:Q82913717-79E3B580-7CD7-4F2D-97DE-9EE680702FC3

wdt:P577

2012-01-27T00:00:00Z

p:P407

wds:Q82913717-76245E53-F5FD-413F-A495-8958358B6A3A

wdt:P407

wd:Q1860

p:P2093

wds:Q82913717-B6A32951-0039-49AC-869E-3567C5DE0923 wds:Q82913717-8635C695-D8BD-4324-9FDD-BD2C52365D76 wds:Q82913717-BA09B8CD-FD91-4029-83A4-9D4CB68504CB wds:Q82913717-C20595E6-7CE6-4713-8D4C-3A651BDE12BF wds:Q82913717-5A690F06-F449-4061-A236-44BBA03A37E4 wds:Q82913717-D7C29CD2-80CD-4EFC-95C4-8B44EC95A1A4 wds:Q82913717-39914B36-6296-42F6-ACE5-5DE93C695110 wds:Q82913717-43E4FD04-71E9-435F-8998-C1055C33705C wds:Q82913717-006D1E2E-4418-476D-85B2-CF498BFEB14E

wdt:P2093

Aiwu Li Guanghui Gao Qinghua Xu Shengxiang Ren Chunxia Su Qinfang Deng Jianfang Xu Caicun Zhou Jian Guo

rdfs:label

Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials

skos:prefLabel

Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials

schema:name

Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials

p:P1476

wds:Q82913717-1D4BEF2A-6D32-4E7A-B602-2BDCAC1B817F

wdt:P1476

Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials

p:P304

wds:Q82913717-CD1A745D-507E-4A9D-AA48-2DF063062108

wdt:P304

E822-9

p:P31

wds:Q82913717-1D7E6C9A-4F40-440D-B9E5-87800B004A39 wds:Q82913717-de391b3e-83c7-4cfb-9a73-4caa87d983be

wdt:P31

wd:Q13442814 wd:Q815382

p:P921

wds:Q82913717-4A848A52-18F5-4CA3-AC7F-E073ACA18990 wds:Q82913717-48B77570-4B38-46E8-88E6-A3F5679254A2

wdt:P921

wd:Q815382 wd:Q42824827

p:P698

wds:Q82913717-7CED9270-8519-44DC-9F58-E749938AC6EF

wdtn:P698

n11:22161771

wdt:P698

22161771

p:P1433

wds:Q82913717-9CFA23CA-C505-493D-B4A6-73995E2C2D35

wdt:P1433

wd:Q332492

p:P433

wds:Q82913717-F14C100E-F9DE-4D97-B8F4-25540E585BF5

p:P478

wds:Q82913717-DC11FDD1-FDF2-47CF-B439-2AEF3225F3AE

wdt:P433

5

wdt:P478

131

p:P356

wds:Q82913717-816AFE8E-58A5-4116-B53F-D5495BF658B5

wdtn:P356

n12:IJC.27396

wdt:P356

10.1002/IJC.27396